Quantification of cell- penetrating peptides and their cargoes

Cell-Penetrating Peptides: Processes and Applications

Volumn , Issue , 2002, Pages 263-275

  Lindgren, Maria ^a   Hällbrink, Mattias ^a   Langel, Ülo ^a  

^a STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 1042294543     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (29)

1. Lindgren, M. et al., Cell-penetrating peptides, Trends Pharmacol. Sci., 21, 99-103, 2000.
2. Hällbrink, M. et al., Cargo delivery kinetics of cell-penetrating peptides, Biochim. Biophys. Acta, 1515, 101-109, 2001.
3. Fawell, S. et al., Tat-mediated delivery of heterologous proteins into cells, Proc. Natl. Acad. Sci. U.S.A., 91, 664-668, 1994.
4. Oehlke, J. et al., Cellular uptake of an alpha-helical amphipathic model peptide with the potential to deliver polar compounds into the cell interior nonendocytically, Biochim. Biophys. Acta, 1414, 127-139, 1998.
5. Lindgren, M. et al., Translocation properties of novel cell-penetrating transportan and penetratin analogues, Bioconjug. Chem., 11, 619-626, 2000.
6. Pooga, M. et al., Cell penetration by transportan, FASEB J., 12, 67-77, 1998.
7. Drin, G. et al., Physico-chemical requirements for cellular uptake of pAntp peptide. Role of lipid-binding affinity, Eur. J. Biochem., 268, 1304-1314, 2001.
8. Scheller, A. et al., Evidence for an amphipathicity independent cellular uptake of amphipathic cell-penetrating peptides, Eur. J. Biochem., 267, 6043-6050, 2000.
9. 125I-containing acylating agent, Biochem. J., 133, 529-538, 1973.
10. Kask, K. et al., Binding and agonist/antagonist actions of M35, galanin(1-13)-bradykinin(2-9)amide chimeric peptide, in Rin m 5F insulinoma cells, Regul. Pept., 59, 341-348, 1995.
11. Fischer, P.M. et al., Structure-activity relationship of truncated and substituted analogues of the intracellular delivery vector penetratin, J. Pept. Res., 55, 163-172, 2000.
12. Meldal, M. and Breddam, K., Anthranilamide and nitrotyrosine as a donor-acceptor pair in internally quenched fluorescent substrates for endopeptidases: multicolumn peptide synthesis of enzyme substrates for subtilisin Carlsberg and pepsin, Anal. Biochem., 195, 141-147, 1991.
13. Wang, Y.L., Fluorescent analog cytochemistry: tracing functional protein components in living cells, Methods Cell Biol., 29, 1-12, 1989.
14. Garcia-Echeverria, C. et al., A new Antennapedia-derived vector for intracellular delivery of exogenous compounds, Bioorg. Med. Chem. Lett., 11, 1363-1366, 2001.
15. Scheller, A. et al., Structural requirements for cellular uptake of alpha-helical amphipathic peptides, J. Pept. Sci., 5, 185-194, 1999.
16. Gazit, E. and Shai, Y., The assembly and organization of the alpha 5 and alpha 7 helices from the pore-forming domain of Bacillus thuringiensis delta-endotoxin. Relevance to a functional model, J. Biol. Chem., 270, 2571-2578, 1995.
17. Elmquist, A. et al., VE-Cadherin-Derived Cell-Penetrating Peptide, pVEC, with carrier functions, Exp. Cell Res., 269, 237-244, 2001.
18. Vives, E., Brodin, P., and Lebleu, B., A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus, J. Biol. Chem., 272, 16010-16017, 1997.
19. Matayoshi, E.D. et al., Novel fluorogenic substrates for assaying retroviral proteases by resonance energy transfer, Science, 247, 954-958, 1990.
20. Kuzmic, P., Program DYNAFIT for the analysis of enzyme kinetic data: application to HIV proteinase, Anal. Biochem., 237, 260-273, 1996.
21. Rojas, M. et al., An alternative to phosphotyrosine-containing motifs for binding to an SH2 domain, Biochem. Biophys. Res. Commun., 234, 675-680, 1997.
22. Dunican, D.J. and Doherty, P., Designing cell-permeant phosphopeptides to modulate intracellular signaling pathways, Biopolymers, 60, 45-60, 2001.
23. Herbert, T.P. et al., Rapid induction of apoptosis mediated by peptides that bind initiation factor eIF4E, Curr. Biol., 10, 793-796, 2000.
24. Chaloin, L. et al., Design of carrier peptide-oligonucleotide conjugates with rapid membrane translocation and nuclear localization properties, Biochem. Biophys. Res. Commun., 243, 601-608, 1998.
25. Pooga, M. et al., Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo, Nat. Biotechnol., 16, 857-8561, 1998.
26. Rousselle, C. et al., New advances in the transport of doxorubicin through the blood-brain barrier by a peptide vector-mediated strategy, Mol. Pharmacol., 57, 679-686, 2000.
27. Mazel, M. et al., Doxorubicin-peptide conjugates overcome multidrug resistance, Anticancer Drugs, 12, 107-116, 2001.
28. Allinquant, B. et al., Downregulation of amyloid precursor protein inhibits neurite outgrowth in vitro, J. Cell Biol., 128, 919-927, 1995.
29. Rousselle, C. et al., Enhanced delivery of doxorubicin into the brain via a peptidevector- mediated strategy: saturation kinetics and specificity, J Pharmacol. Exp. Ther., 296, 124-131, 2001.